A new original research article in SLAS Discovery presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5′-Nucleotidase, a promising target for developing anti-cancer drugs.
A new original research article in SLAS Discovery presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5′-Nucleotidase, a promising target for developing anti-cancer drugs.